Anne Marie Bertucci

424 citations
7 papers · 332 indexed · h-index 7
Topics
Estrogen and related hormone effects (3 papers)HER2/EGFR in Cancer Research (2 papers)Systemic Lupus Erythematosus Research (2 papers)

In The Last Decade

Anne Marie Bertucci

7 papers receiving 329 citations

Peers

Anne Marie Bertucci
Comparison fields: 5 of 60
  • Immunology 154
  • Genetics 86
  • Oncology 82
  • Molecular Biology 76
  • Rheumatology 64
Replace Seigou Abiru with:
Seigou Abiru Japan
Toshimitsu Majima Japan
Michaela Oswald United States
Toshihiko Nouchi Japan
Diane M. Pierson United States
Patricia A. Toniolo United States
Yongzeng Ding United States
Anne Marie Bertucci relative to Seigou Abiru Japan Seigou Abiru's profile →
Citations per field
00.5×3.9×
Seigou Abiru · 1×
Citations per year

Countries citing papers authored by Anne Marie Bertucci

Since Specialization
Citations

This map shows the geographic impact of Anne Marie Bertucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Marie Bertucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Marie Bertucci more than expected).

Fields of papers citing papers by Anne Marie Bertucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Marie Bertucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Marie Bertucci. The network helps show where Anne Marie Bertucci may publish in the future.

Co-authorship network of co-authors of Anne Marie Bertucci

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Marie Bertucci. A scholar is included among the top collaborators of Anne Marie Bertucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Marie Bertucci. Anne Marie Bertucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 28
2 127
3 40
4 52
5 30
6
Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
29
7 26

About Anne Marie Bertucci

Anne Marie Bertucci is a scholar working on Toxicology, Immunology and Cancer Research, having authored 7 papers that have together received 332 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (3 papers), HER2/EGFR in Cancer Research (2 papers) and Systemic Lupus Erythematosus Research (2 papers). The work is most often cited by research in Immunology (154 citations), Rheumatology (64 citations) and Genetics (86 citations). Anne Marie Bertucci has collaborated with scholars based in United States, United Kingdom and Chile. Frequent co-authors include Syamal K. Datta, Rosalind Ramsey‐Goldman, Richard K. Burt, Li Zhang, Luting Xu, Li Zhang, V. Craig Jordan, Richard M. Pope, Clodia Osipo and Dong Cheng. Their work appears in journals such as The Journal of Immunology, Clinical Cancer Research and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026